CAS: 937275-23-5; (R,E)-2-(1-(((3-(2-Acetylphenyl)-1-(3-(2-(7-Chloroquinolin-2-yl)Vinyl)Phenyl)Propyl)Thio)Methyl)Cyclopropyl)Acetic Acid

该化合物是治疗哮喘和过敏炎时常用的与蒙泰卢卡斯特有关的化学化合物,其特征是结构改变,以提高其药理特性;典型地,该化合物具有分子结构,包括一个可影响其反应和与生物目标互动的Ketone功能组; Montelukast Metem Ketone预计将产生与其母化合物相似的治疗效果,有可能提供更好的功效或改变药理动力学;就物理特性而言,该化合物在室内温度上可能呈现固体或液体,取决于其具体的配方和纯度;该化合物的溶解性,稳定性和生物利用率是决定其是否适合药物应用的关键因素;与许多化学物质一样,安全和处理预防措施对于减轻与使用该化合物有关的任何潜在风险至关重要,特别是在实验室或临床环境中.

结构式图片

上下游产品

CAS号855473-50-6 2-[1-(溴甲基)环丙基]乙酸甲酯 | CAS号149968-11-6 (E)-2-[3-[3-[2-... | CAS号181139-72-0 [S-(E)]-2-[3-[3... | CAS号851755-56-1 2'-去(1-羟基-1-甲基乙... | CAS号676-58-4 甲基氯化镁 | CAS号158966-92-8 孟鲁司特

合成工艺路线路线简述

  • 162515-68-6 + 2102026-29-7 = 937275-23-5
    反应条件:1.1 Reagents: Potassium Hydroxide Solvents: Acetonitrile; 20 °C; 0.5 H,Rt1.2 Solvents: Acetonitrile; Rt; Rt -> 30 °C; 3 H,30 °C
    标题:Montelukast Sodium Intermediate And Preparation Method And Application Thereof In Preparation Of Montelukast Sodium As Anti-Asthma Drug
    参考文献:World Intellectual Property Organization]

    = 937275-23-5 [标题:Reaction Conditions
    标题:Process For Preparation Of Montelukast And Related Compounds
    参考文献:World Intellectual Property Organization]

    2102026-29-7 + 71199-15-0 = 937275-23-5
    反应条件:1.1 Reagents: Potassium Hydroxide Solvents: Acetonitrile; 20 °C; 0.5 H,Rt1.2 Solvents: Acetonitrile; Rt; 3 H,Rt -> 30 °C
    标题:Montelukast Sodium Intermediate And Preparation Method And Application Thereof In Preparation Of Montelukast Sodium As Anti-Asthma Drug
    参考文献:China]

    676-58-4 + 851755-56-1 = 937275-23-5
    反应条件:1.1 Solvents: Tetrahydrofuran; 3 H,0 °C; 6 H,0 °C
    标题:Identification,Synthesis And Characterization Of Impurities Of Montelukast Sodium
    作者:Kumar,I. V. Sunil; Anjaneyulu,G. S. R.; Bindu,V. Hima
    参考文献:Asian Journal Of Chemistry 日期:2011 卷标:23(10) 页码:4536-4546
📜[s-(E)]-2-[3-[3-[2-(7-氯-2-喹啉基)乙烯基]苯基]-3-羟基丙基]苯甲酸甲酯置于sodium Methylate,N,N-二异丙基乙胺体系中,用 四氢呋喃,甲醇,二氯甲烷,N,N-二甲基甲酰胺 作为反应溶剂,化学反应 32.5H,反应生成 孟鲁司特杂质f
参考文献:Sunil Kumar; Anjaneyulu; Hima Bindu,Asian Journal Of Chemistry,2011,Vol. 23,# 10,P. 4536-4546
标题:Sunil Kumar; Anjaneyulu; Hima Bindu,Asian Journal Of Chemistry,2011,Vol. 23,# 10,P. 4536-4546

海关参考信息

专利信息


专利号:US-7786138-B2
优先权日:2005-11-18
标题 :Process for making montelukast and intermediates therefor
发明人:BENOVSKY PETR; THIJS LAMBERTUS; OVEREEM ARJANNE; CASTULIK JAKUB; ZHU JIE; BARTOS PETR; SKOUMAL RADOMIR
权利人:SYNTHON BV
摘要:A compound of the following formula n nwherein R′ is a straight or branched C1-C4 alkyl group is useful in processes associated with the synthesis of montelukast and its salts.

专利号:WO-2008035086-A2
优先权日:2006-09-22
标题:Synthesis of leukotriene compounds

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Paljarvi T, Forton J, Luciano S, Herttua K, Fazel S. Analysis of Neuropsychiatric Diagnoses After Montelukast Initiation. JAMA Netw Open. 2022 May 2;5(5):e2213643. doi: 10.1001/jamanetworkopen.2022.13643.
2: Markham A, Faulds D. Montelukast. Drugs. 1998 Aug;56(2):251-6; discussion 257. doi: 10.2165/00003495-199856020-00010. 11(7):2096-2103.e1. doi: 10.1016/j.jaip.2023.03.010. Epub 2023 Mar 21. 24(5):551-555. doi: 10.1080/14656566.2023.2192866. Epub 2023 Mar 19. 49(4):417-428. doi: 10.1111/coa.14169. Epub 2024 May 3. 62(3):376-385. doi: 10.1080/02770903.2024.2415544. Epub 2025 Jan 2. 12(1):e053112. doi: 10.1136/bmjopen-2021-053112.
8: Jafari M, Sobhani M, Eftekhari K, Malekiantaghi A, Gharagozlou M, Shafiei A. The Effect of Oral Montelukast in Controlling Asthma Attacks in Children: A Randomized Double-blind Placebo Control Study. Iran J Allergy Asthma Immunol. 2023 Oct 29;22(5):413-419. doi: 10.18502/ijaai.v22i5.13990. 40(5):939-42. doi: 10.1345/aph.1G006. Epub 2006 May 2. 80(17):1831-1851. doi: 10.1007/s40265-020-01406-9. 63(1):45-54. doi: 10.20471/acc.2024.63.01.6.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知